Convertibles Calendar: Immunocore on deck

Jan. 30

IMMUNOCORE HOLDINGS PLC.

• $300 million six-year convertible notes

• $45 million greenshoe

• Coupon of 2.5% to 3% and initial conversion premium of 30% to 35%

• Non-callable for three years and then subject to a 130% hurdle

• Rule 144A

• J.P. Morgan Securities LLC

• Proceeds to support the company’s clinical pipeline and commercial expansion, to repay in full loans under its loan agreement with Pharmakon Advisors LP and for general corporate purposes

• Rockville, Md.-based commercial stage biotechnology company

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.